14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for TCON

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.94 6.98 %
R2 1.88 4.03 %
R1 1.85 2.21 %
Current price: 1.81
Support S1 1.74 -3.69 %
S2 1.71 -5.51 %
S3 1.66 -8.46 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.11 16.57 %
R2 1.96 8.29 %
R1 1.87 3.57 %
Current price 1.81
Support S1 1.80 -0.552%
S2 1.73 -4.42%
S3 1.71 -5.52%

TCON Predictions History

3 years ago
sander7100 yo bro predicted that TCON for 2020-08-18 is going $1.84 (14.29%)

3 years ago
JS predicted that TCON for 2020-08-18 is going $1.85 (14.91%)

3 years ago
iHustle84 predicted that TCON for 2020-08-18 is going $1.90 (18.01%)

3 years ago
William Bernhardt predicted that TCON for 2020-08-18 is going

Rank:

4 years ago
JS predicted that TCON for 2020-01-13 is going $3.06 (13.33%)

5 years ago
Gp predicted that TCON for 2019-03-04 is going $1.11 (3.35%)

5 years ago
PumpTheseNumbers predicted that TCON for 2019-03-04 is going $1.12 (4.28%)

5 years ago
JS predicted that TCON for 2019-03-04 is going $1.06 (-1.30%)

6 years ago
JS predicted that TCON for 2017-10-23 is going $3.10 (1.64%)

Click to get the best stock tips daily for free!

About TRACON Pharmaceuticals

TRACON Pharmaceuticals TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of soft tissue sarcoma; and YH001, an investigational humanized CTLA-4 IgG1 monoclonal antibody for the treatment of various cancer indications. The company's clinical stage products also... TCON Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT